相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。CD141+ dendritic cells produce prominent amounts of IFN-α after dsRNA recognition and can be targeted via DEC-205 in humanized mice
Sonja Meixlsperger et al.
BLOOD (2013)
Robust T-cell stimulation by Epstein-Barr virus-transformed B cells after antigen targeting to DEC-205
Carol S. Leung et al.
BLOOD (2013)
Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation
Ann M. Leen et al.
BLOOD (2013)
Phase I Trial of Recombinant Modified Vaccinia Ankara Encoding Epstein-Barr Viral Tumor Antigens in Nasopharyngeal Carcinoma Patients
Edwin P. Hui et al.
CANCER RESEARCH (2013)
Infectious diseases in humanized mice
Carol Leung et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2013)
CD8+ T Cell Responses to Lytic EBV Infection: Late Antigen Specificities as Subdominant Components of the Total Response
Rachel J. M. Abbott et al.
JOURNAL OF IMMUNOLOGY (2013)
An Epstein-Barr Virus Mutant Produces Immunogenic Defective Particles Devoid of Viral DNA
Sophia Pavlova et al.
JOURNAL OF VIROLOGY (2013)
A novel tetrameric gp3501-470 as a potential Epstein-Barr virus vaccine
Xinle Cui et al.
VACCINE (2013)
Spontaneous Lytic Replication and Epitheliotropism Define an Epstein-Barr Virus Strain Found in Carcinomas
Ming-Han Tsai et al.
CELL REPORTS (2013)
Human Natural Killer Cells Prevent Infectious Mononucleosis Features by Targeting Lytic Epstein-Barr Virus Infection
Obinna Chijioke et al.
CELL REPORTS (2013)
Human Complement Receptor Type 1/CD35 Is an Epstein-Barr Virus Receptor
Javier G. Ogembo et al.
CELL REPORTS (2013)
Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation
Ekaterina Doubrovina et al.
BLOOD (2012)
EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors
Robert E. White et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
TCR Bias and HLA Cross-Restriction Are Strategies of Human Brain-Infiltrating JC Virus-Specific CD4+ T Cells during Viral Infection
Sara Yousef et al.
JOURNAL OF IMMUNOLOGY (2012)
An Epstein-Barr Virus Encoded Inhibitor of Colony Stimulating Factor-1 Signaling Is an Important Determinant for Acute and Persistent EBV Infection
Makoto Ohashi et al.
PLOS PATHOGENS (2012)
A New Model of Epstein-Barr Virus Infection Reveals an Important Role for Early Lytic Viral Protein Expression in the Development of Lymphomas
Shi-Dong Ma et al.
JOURNAL OF VIROLOGY (2011)
A Virus-Like Particle-Based Epstein-Barr Virus Vaccine
Romana Ruiss et al.
JOURNAL OF VIROLOGY (2011)
Allogeneic virus-specific T cells with HLA alloreactivity do not produce GVHD in human subjects
J. Joseph Melenhorst et al.
BLOOD (2010)
Human NK cells of mice with reconstituted human immune system components require preactivation to acquire functional competence
Till Strowig et al.
BLOOD (2010)
Trafficking, Persistence, and Activation State of Adoptively Transferred Allogeneic and Autologous Simian Immunodeficiency Virus-Specific CD8(+) T Cell Clones during Acute and Chronic Infection of Rhesus Macaques
Diane L. Bolton et al.
JOURNAL OF IMMUNOLOGY (2010)
Infectious Mononucleosis
Katherine Luzuriaga et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Generation of functional human T-cell subsets with HLA-restricted immune responses in HLA class I expressing NOD/SCID/IL2rγnull humanized mice
Leonard D. Shultz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Priming of protective T cell responses against virus-induced tumors in mice with human immune system components
Till Strowig et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Quantitative evaluation of the role of Epstein-Barr virus immediate-early protein BZLF1 in B-cell transformation
Koichi Ricardo Katsumura et al.
JOURNAL OF GENERAL VIROLOGY (2009)
Targeting the nuclear antigen I of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses
Cagan Gurer et al.
BLOOD (2008)
Standardized and highly efficient expansion of Epstein-Barr virus-specific CD4+ T cells by using virus-like particles
Dinesh Adhikary et al.
JOURNAL OF VIROLOGY (2008)
Rhesus Lymphocryptovirus Type 1-associated B-cell Nasal Lymphoma in SIV-infected Rhesus Macaques
A. K. Marr-Belvin et al.
VETERINARY PATHOLOGY (2008)
Recombinant gp350 vaccine for infectious mononucleosis: A phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults
Etienne M. Sokal et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial
Tanzina Haque et al.
BLOOD (2007)
Immunodominance of Lytic Cycle Antigens in Epstein-Barr Virus-Specific CD4+T Cell Preparations for Therapy
Dinesh Adhikary et al.
PLOS ONE (2007)
Control of Epstein-Barr virus infection in vitro by T helper cells specific for virion glycoproteins
D Adhikary et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model
GK Hong et al.
JOURNAL OF VIROLOGY (2005)
Impaired transporter associated with antigen processing-dependent peptide transport during productive EBV infection
ME Ressing et al.
JOURNAL OF IMMUNOLOGY (2005)
Defective infectious particles and rare packaged Genomes produced by cells carrying terminal-repeat-negative Epstein-Barr virus
R Feederle et al.
JOURNAL OF VIROLOGY (2005)
CD8+ immunodominance among Epstein-Barr virus lytic cycle antigens directly reflects the efficiency of antigen presentation in lytically infected cells
VA Pudney et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Dual stimulation of Epstein-Barr virus (EBV)-specific CD4(+)- and CD8(+)-T-cell responses by a chimeric antigen construct: potential therapeutic vaccine for EBV-positive nasopharyngeal carcinoma
GS Taylor et al.
JOURNAL OF VIROLOGY (2004)
Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells
T Haque et al.
LANCET (2002)
Generation of high quantities of viral and tumor-specific human CD4+and CD8+T-cell clones using peptide pulsed mature dendritic cells
JF Fonteneau et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2001)
The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators
R Feederle et al.
EMBO JOURNAL (2000)
Human CD4+ T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1
C Münz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)